Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1894977 | 0.97 | CNR1 (0.81) | CNR1CNR2 | |
| SCHEMBL4456833 | 0.93 | CNR1 (0.75) | CNR1CNR2 | |
| SCHEMBL1897698 | 0.93 | CNR1 (1.00) | CNR1CNR2 | |
| SCHEMBL3371294 | 0.92 | CNR1 (0.82) | CNR1CNR2 | |
| SCHEMBL3372769 | 0.90 | CNR1 (0.94) | CNR1CNR2 | |
| SCHEMBL3368705 | 0.88 | CNR1 (0.86) | CNR1CNR2 | |
| SCHEMBL13894032 | 0.87 | CNR1 (0.65) | CNR1CNR2 | |
| SCHEMBL2730879 | 0.86 | CNR1 (0.86) | CNR1CNR2 | |
| SCHEMBL3528222 | 0.86 | CNR1 (1.00) | CNR1CNR2 | |
| SCHEMBL3374706 | 0.86 | CNR1 (1.00) | CNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1879582-A4 | COMBINATION OF DIPEPTIDYL PEPTIDASE-IV INHIBITOR AND A CANNABINOID CB1 RECEPTOR ANTAGONIST FOR THE TREATMENT OF DIABETES AND OBESITY | MERCK & CO INC (US) | 2009-05-13 | — | — | EP | claimed |
| EP-1879582-A2 | COMBINATION OF DIPEPTIDYL PEPTIDASE-IV INHIBITOR AND A CANNABINOID CB1 RECEPTOR ANTAGONIST FOR THE TREATMENT OF DIABETES AND OBESITY | Merck & Co., Inc. (US) | 2008-01-23 | — | — | EP | claimed |
| WO-2006119260-A2 | COMBINATION OF DIPEPTIDYL PEPTIDASE-IV INHIBITOR AND A CANNABINOID CB1 RECEPTOR ANTAGONIST FOR THE TREATMENT OF DIABETES AND OBESITY | MERCK & CO., INC. (US) | 2006-11-09 | — | — | WO | claimed |